Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Collins

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Pediatric Blood & Cancer|March 10, 2025
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte-Predominant Hodgkin LymphomaMonica Palese, Ranjana H Advani, Dominic Biney-Amissah, et al.
British Journal of Haematology|June 22, 2019
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphomaFaouzi Djebbari, Joseph A Browning, Louise Stanton, et al.
Blood Advances|March 4, 2026
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 yearsAndrew Challenger, Paul McGale, Jake Probert, et al.
Blood Advances|September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trialAlex F Herrera, Catherine Burton, John Radford, et al.
The Lancet. Haematology|July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphomaSean H Lim, Nicola Campbell, Marina Johnson, et al.
Haematologica|September 8, 2018
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapyToby A Eyre, Harriet S Walter, Sunil Iyengar, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|November 27, 2024
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across EnglandDavid A Jones, Katie Spencer, Johanna Ramroth, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Haematologica|October 5, 2023
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Pediatric Blood & Cancer|March 10, 2025
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte-Predominant Hodgkin LymphomaMonica Palese, Ranjana H Advani, Dominic Biney-Amissah, et al.
British Journal of Haematology|June 22, 2019
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphomaFaouzi Djebbari, Joseph A Browning, Louise Stanton, et al.
Blood Advances|March 4, 2026
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 yearsAndrew Challenger, Paul McGale, Jake Probert, et al.
Blood Advances|September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trialAlex F Herrera, Catherine Burton, John Radford, et al.
The Lancet. Haematology|July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphomaSean H Lim, Nicola Campbell, Marina Johnson, et al.
Haematologica|September 8, 2018
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapyToby A Eyre, Harriet S Walter, Sunil Iyengar, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|November 27, 2024
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across EnglandDavid A Jones, Katie Spencer, Johanna Ramroth, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Haematologica|October 5, 2023
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, et al.
Pageof 17